Filing Flows › Haemonetics (HAE) › Capital expenditures
Haemonetics (HAE) capital expenditures by quarter
Haemonetics' capital expenditures were $14.8M in Q2 FY27 (second quarter fiscal 2027), +93% from Q1 FY27. Over the last 7 quarters it ranged from $5.0M (Q2 FY26) to $17.7M (Q4 FY26).
| Quarter | Capital expenditures | Q/Q | Y/Y |
|---|---|---|---|
| Q2 FY27 | $14.8M | +93% | +194% |
| Q1 FY27 | $7.7M | -57% | -31% |
| Q4 FY26 | $17.7M | +178% | +13% |
| Q3 FY26 | $6.3M | +27% | — |
| Q2 FY26 | $5.0M | -55% | — |
| Q1 FY26 | $11.2M | -29% | — |
| Q4 FY25 | $15.6M | — | — |
Q2 FY27 at a glance
Haemonetics, Q2 FY27: revenue $358M (+9% year over year), operating margin 21.0%, net earnings $46.3M, operating cash flow $128M. The chart follows the revenue to costs, profit and cash.
Questions
What is Haemonetics' capital expenditures?
Haemonetics' capital expenditures were $14.8M in Q2 FY27 (second quarter fiscal 2027), +93% from Q1 FY27.
How has Haemonetics' capital expenditures changed?
Over the last 7 quarters it ranged from $5.0M (Q2 FY26) to $17.7M (Q4 FY26).